\(
\def\WIPO{World Intellectual Property Organisation}
\)
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Détails
Titre
Not all pharma IP law is transferable.
Type d’élément
Journal article
Description
GB 139 May 2010, p. 96; [28] cm
ISSN
2044-7175
Autre cote
GB 139
Résumé
The battle for supremacy between Europe and the US in the fields of pharmaceutical R&D and innovation has pointlessly flared up once again. A recently published survey by international intellectual property specialists Marks & Clerk indicates that the US IP system is viewed as being more favourable to innovation and that President Obama's recently passed healthcare reforms are proving to be increasingly palatable for big pharma.
Publié
London, England: Informa, U.K. 2010.
Langue
Anglais
Le document apparaît dans